Hims & Hers Health, Inc. (HIMS) Stock
1 member of Congress disclosed 1 trade in HIMS since 2025: 1 purchase and 0 sales, most recently Lisa McClain (purchase, Aug 4, 2025). 4 of the hedge funds AlphaScala tracks reported HIMS in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Marshall Wace's at $146.23M. Company insiders reported 0 open-market buys and 14 sales on SEC Form 4 in the 90 days to Nov 6, 2026.
Which members of Congress traded Hims & Hers Health, Inc. (HIMS)?
Most recent: Lisa McClain (purchase, Aug 4, 2025); records start Aug 4, 2025.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Lisa McClain R-MI · House | 2025-08-04 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026.
See all HIMS political trades →Which hedge funds own HIMS?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Marshall Wace | 4.22M | $146.23M | +482% |
| Citadel Ken Griffin | 847K | $29.36M | +22% |
| D.E. Shaw David Shaw | 172K | $5.95M | -71% |
| Bridgewater Associates Ray Dalio | 7K | $243.9K | -83% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Hims & Hers Health, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 28, 26 | Boughton Soleil | Chief Legal Officer | SELL | 3.5K | $96K |
| Oct 14, 26 | Boughton Soleil | Chief Legal Officer | SELL | 3.5K | $101K |
| Oct 1, 26 | Okupe Oluyemi | Chief Financial Officer | SELL | 2.0K | $59K |
| Sep 30, 26 | Boughton Soleil | Chief Legal Officer | SELL | 3.5K | $101K |
| Sep 22, 26 | Okupe Oluyemi | Chief Financial Officer | SELL | 29.3K | $877K |
| Sep 17, 26 | Okupe Oluyemi | Chief Financial Officer | SELL | 12.3K | $355K |
| Sep 16, 26 | Boughton Soleil | Chief Legal Officer | SELL | 6.2K | $174K |
| Sep 15, 26 | Chi Michael | Chief Operating Officer | SELL | 14.0K | $398K |
| Sep 15, 26 | Elshenawy Mohamed | CTO | SELL | 8.0K | $226K |
| Sep 2, 26 | Boughton Soleil | Chief Legal Officer | SELL | 3.5K | $98K |
SEC Form 4 filings as of Nov 6, 2026
See cluster-buy signals across all tickers →HIMS price chart
Powered by TradingViewWhat does Hims & Hers Health, Inc. do?
Hims & Hers Health, Inc. is a leading telehealth platform that connects consumers to licensed healthcare professionals for personalized medical care. The company operates a direct-to-consumer model, offering consultations, prescription medications, over-the-counter products, and wellness solutions across specialties including sexual health, hair care, skincare, mental health, weight loss, dermatology, and primary care. Customers engage through a secure online intake process, receive evaluations from vetted providers in all 50 U.S. states and internationally in countries like the United Kingdom, Canada, Germany, France, Spain, and Ireland, and access treatments shipped discreetly from partner pharmacies. Hims & Hers emphasizes asynchronous messaging for convenience, ongoing clinical support, educational resources, laboratory testing for biomarkers, and curated non-prescription items such as supplements, cosmetics, and devices focused on general wellness. Founded in 2017 and headquartered in San Francisco, California, the platform prioritizes clinical quality, customer privacy, and accessibility to normalize health challenges and empower informed decisions.